RT Journal Article SR Electronic T1 Associations between transdiagnostic psychological processes and global symptom severity among outpatients with various mental disorders: A cross-sectional study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.06.24.24309393 DO 10.1101/2024.06.24.24309393 A1 Frei, Anna Katharina A1 Studnitz, Thomas A1 Seiffer, Britta A1 Welkerling, Jana A1 Zeibig, Johanna-Marie A1 Herzog, Eva A1 Günak, Mia Maria A1 Ehring, Thomas A1 Takano, Keisuke A1 Nakagawa, Tristan A1 Sundmacher, Leonie A1 Himmler, Sebastian A1 Peters, Stefan A1 Flagmeier, Anna Lena A1 Zwanzleitner, Lena A1 Ramos-Murguialday, Ander A1 Wolf, Sebastian YR 2024 UL http://medrxiv.org/content/early/2024/06/25/2024.06.24.24309393.abstract AB Objective Knowledge about transdiagnostic factors associated with global symptom severity among patients diagnosed with various mental disorders remains limited. This study examined the cross-sectional associations between transdiagnostic psychological processes (emotional regulation, emotional intelligence, sleep quality, perceived stress, fear of the coronavirus, repetitive negative thinking), amount of physical activity, and sedentary behavior with global symptom severity, while controlling for sociodemographic data (age, gender, employment status, relationship status, educational level).Methods Data from 401 outpatients, aged 42.08 years on average (SD = 13.26; 71.3% female), diagnosed with depressive disorders, non-organic primary insomnia, agoraphobia, panic disorder, and/or posttraumatic stress disorder were analyzed. Data was collected from 10 different study sites between March 2021 and May 2022 for cross-sectional analysis. The influence of predictors of global symptom severity was determined using multiple regression. Global symptom severity was measured using the Global Severity Index, derived from the Brief Symptom Inventory-18. Predictors were measured using validated scales and physical activity was additionally assessed via accelerometer-based sensors.Results The proposed model explained 40.3% of variance on the Global Severity Index. Higher levels of repetitive negative thinking, fear of coronavirus, perceived stress, worse sleep quality as well as greater difficulties with emotional regulation and emotional intelligence were significantly associated with higher global symptom severity in our clinical outpatient sample; however, no associations were found for physical activity, and sedentary behavior.Conclusion Transdiagnostic psychological processes were significantly associated with global symptom severity. Additional prospective longitudinal studies with transdiagnostic samples are necessary to explore possible causal relationships.Key Practitioner MessageRepetitive negative thinking, perceived stress, sleep quality, and emotional regulation can be considered distinct and individual transdiagnostic psychological processes associated with global symptom severity among outpatients diagnosed with various mental disorders.Treatment approaches aiming at improving transdiagnostic predictors of various mental disorders might be an efficacious target in reducing global symptom severity.Among outpatients (75% already receiving psychological or pharmacological treatment) diagnosed with depressive disorders, non-organic primary insomnia, agoraphobia, panic disorder, and/or PTSD, sociodemographic factors appear not to be predictive for global symptom severity.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialDRKS00024152Funding StatementThis study was funded by the German Innovation Fund of the Federal Joint Committee (grant number: 01NVF19022).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee for medical research at the University of Tuebingen gave ethical approval for this work(ID: 888/2020B01, 02/11/2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://osf.io/5rcuz/files/osfstorage. https://osf.io/5rcuz/files/osfstorage